Charles Deignan

Insider Reports History

Location
Alpharetta, GA
Signature
/s/ Charles Deignan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Deignan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Clearside Biomedical, Inc. Chief Financial Officer Common Stock 385K $489K $1.27 Jan 19, 2024 Direct
Clearside Biomedical, Inc. Chief Financial Officer Employee Stock Option (right to buy) 200K Jan 8, 2025 Direct
Clearside Biomedical, Inc. Chief Financial Officer Employee Stock Option (right to buy) 200K Jan 18, 2024 Direct

Insider Reports Filed by Charles Deignan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CLSD Clearside Biomedical, Inc. Jan 8, 2025 1 $0 4 Jan 10, 2025 Chief Financial Officer
CLSD Clearside Biomedical, Inc. Jan 18, 2024 2 -$16.5K 4 Jan 19, 2024 Chief Financial Officer
CLSD Clearside Biomedical, Inc. Sep 18, 2023 1 $0 4 Sep 20, 2023 Chief Financial Officer
CLSD Clearside Biomedical, Inc. Sep 13, 2023 2 $13.6K 4 Sep 13, 2023 Chief Financial Officer
CLSD Clearside Biomedical, Inc. Jan 19, 2023 1 -$21K 4 Jan 20, 2023 Chief Financial Officer
CLSD Clearside Biomedical, Inc. Jan 4, 2023 1 $0 4 Jan 6, 2023 Chief Financial Officer
CLSD Clearside Biomedical, Inc. Dec 20, 2022 2 $9.45K 4 Dec 20, 2022 Chief Financial Officer
CLSD Clearside Biomedical, Inc. Jan 18, 2022 2 $0 4/A Jan 28, 2022 Chief Financial Officer
CLSD Clearside Biomedical, Inc. Sep 21, 2021 1 -$17.9K 4 Sep 23, 2021 Chief Financial Officer
CLSD Clearside Biomedical, Inc. Jun 21, 2021 1 -$12.8K 4 Jun 23, 2021 Chief Financial Officer